Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Selcia

Selcia?uq=w9if130k
2001 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of drug discovery services intended to identifying the active ingredient by serendipitous discovery. The company's services include lead discovery, medicinal chemistry services, proprietary fragment screening and other related services, enabling pharma, biotechnology companies and academic institutions to receive integrated drug discovery services. The company also provides radiolabelling and chemical analytical services.

Website
Formerly Known As
Scynexis Europe
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • Fyfield Business And Research Park
  • Fyfield Road
  • Ongar CM5 0GS
  • England

+44 01277 000000

Selcia Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Selcia‘s full profile, request access.

Request full access to PitchBook

Selcia Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Selcia‘s full profile, request access.

Request full access to PitchBook

Selcia Executive Team (3)

Name Title Board
Seat
Contact
Info
Hans Fliri Ph.D Chief Executive Officer & Chairman
Clive Cornell Chief Operating Officer & Co-Founder
Dave Roberts Business Development Director & Co-Founder

Selcia Board Members (1)

Name Representing Role Since Contact
Info
0000 00000 00.0 Selcia Chief Executive Officer & Chairman 000 0000